NCT04770220: An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
- State
- Completed
- Phase
- Phase 3
- People
- 325 taking part
- Started
- 19 May 2021
- Primary completion
- 29 May 2024
- Arms
- ALZ-801
- Results
- Posted on the registry
- 25 Feb 2021: Trial registered
- 19 May 2021: Trial started
- 29 Jul 2024: Trial completed
- 10 Nov 2025: Trial results posted